Department of Cardiovascular Surgery, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167 North Lishi Road, Xicheng District, Beijing, 100037, China.
Adv Exp Med Biol. 2020;1177:75-100. doi: 10.1007/978-981-15-2517-9_3.
Coronary revascularization is the most important strategy for coronary artery disease. This review summarizes the current most prevalent approaches for coronary revascularization and discusses the evidence on the mechanisms, indications, techniques, and outcomes of these approaches. Targeting coronary thrombus, fibrinolysis is indicated for patients with diagnosed myocardial infarction and without high risk of severe hemorrhage. The development of fibrinolytic agents has improved the outcomes of ST-elevation myocardial infarction. Percutaneous coronary intervention has become the most frequently performed procedure for coronary artery disease. The evolution of stents plays an important role in the result of the procedure. Coronary artery bypass grafting is the most effective revascularization approach for stenotic coronary arteries. The choice of conduits and surgical techniques are important determinants of patient outcomes. Multidisciplinary decision-making should analyze current evidence, considering the clinical condition of patients, and determine the safety and necessity for coronary revascularization with either PCI or CABG. For coronary artery disease with more complex lesions like left main disease and multivessel disease, CABG results in more complete revascularization than PCI. Furthermore, comorbidities, such as heart failure and diabetes, are always correlated with adverse clinical events, and a routine invasive strategy should be recommended. For patients under revascularization, secondary prevention therapies are also of important value for the prevention of subsequent adverse events.
冠状动脉血运重建是治疗冠状动脉疾病的最重要策略。本综述总结了目前最流行的冠状动脉血运重建方法,并讨论了这些方法的机制、适应证、技术和结果的证据。针对冠状动脉血栓,纤溶疗法适用于诊断为心肌梗死且无严重出血高风险的患者。纤溶剂的发展改善了 ST 段抬高型心肌梗死的结局。经皮冠状动脉介入治疗已成为治疗冠状动脉疾病最常进行的手术。支架的发展在手术结果中起着重要作用。冠状动脉旁路移植术是治疗狭窄性冠状动脉疾病最有效的血运重建方法。移植物和手术技术的选择是患者结局的重要决定因素。多学科决策应分析当前的证据,考虑患者的临床状况,并确定经皮冠状动脉介入治疗或冠状动脉旁路移植术进行冠状动脉血运重建的安全性和必要性。对于左主干病变和多支血管病变等更复杂病变的冠状动脉疾病,冠状动脉旁路移植术比经皮冠状动脉介入治疗能更完全地进行血运重建。此外,心力衰竭和糖尿病等合并症总是与不良临床事件相关,应推荐常规的有创策略。对于需要血运重建的患者,二级预防治疗对于预防随后的不良事件也具有重要价值。